Bantam Pharmaceutical Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Investors
  • 3

Bantam Pharmaceutical General Information

Description

Operator of a drug discovery platform intended to develop therapeutics that address the unmet needs of cancer patients. The company offers a new therapeutic approach featuring the tumor-killing potency of chemotherapy but with the selected targeted therapy that will expand the treatment options for relapsed and refractory lymphomas and difficult-to-treat solid tumors, enabling patients to effectively fight cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 8 Davis Drive
  • Durham, NC 27709
  • United States
+1 (646) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bantam Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC Cancelled Clinical Trials - General
3. Later Stage VC (Series A) 16-Sep-2021 Cancelled Clinical Trials - General
2. Seed Round 16-Sep-2021 $25M $32M Completed Clinical Trials - General
1. Seed Round 11-Aug-2015 $7M $7M Completed Startup
To view Bantam Pharmaceutical’s complete valuation and funding history, request access »

Bantam Pharmaceutical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a drug discovery platform intended to develop therapeutics that address the unmet needs of cancer patients.
Drug Discovery
Durham, NC
8 As of 2024
0000
00000 00000

000000

nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Du
0000000000000
Gaithersburg, MD
00 As of 0000
00000
00000000 00000

000000

or sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut la
000000000000000
Karachi, Pakistan
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bantam Pharmaceutical Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
Pfizer Pakistan Corporation Karachi, Pakistan
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden 00 000.00 0000000000 0 000.00
Cardurion Pharma Venture Capital-Backed Burlington, MA 00 00000 00000000000 00000
Kite Pharma Formerly VC-backed Santa Monica, CA 0000 00000 000000&0 00000
You’re viewing 5 of 8 competitors. Get the full list »

Bantam Pharmaceutical Patents

Bantam Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220162204-A1 Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative Pending 31-May-2019 0000000000
AU-2020283129-A1 Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative Pending 31-May-2019 0000000000
JP-2022534429-A Crystal polymorph of 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative Pending 31-May-2019 0000000000
US-20220267314-A1 Methods for making thiazolypyrazole carboxylic acids and intermediates therefor Pending 31-May-2019 0000000000
JP-2022535228-A Process for the preparation of thiazolylpyrazole carboxylic acids and intermediates therefor Pending 31-May-2019 C07D417/04
To view Bantam Pharmaceutical’s complete patent history, request access »

Bantam Pharmaceutical Executive Team (5)

Name Title Board Seat Contact Info
Michael Stocum Chief Executive Officer, President & Board Member
Matthew Kostura Ph.D Chief Scientific Officer
Victor Keen Co-Founder & Board of Manager
Zahid Bashir MD Chief Medical Officer
You’re viewing 4 of 5 executive team members. Get the full list »

Bantam Pharmaceutical Board Members (4)

Name Representing Role Since
James Tozer Jr. Bantam Pharmaceutical Board Member 000 0000
Lionel Goldfrank III Self Board Member 000 0000
Michael Stocum Bantam Pharmaceutical Chief Executive Officer, President & Board Member 000 0000
Victor Keen Bantam Pharmaceutical Co-Founder & Board of Manager 000 0000
To view Bantam Pharmaceutical’s complete board members history, request access »

Bantam Pharmaceutical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bantam Pharmaceutical Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Lionel Goldfrank Angel (individual) Minority 000 0000 000000 0
Victor Keen Angel (individual) Minority 000 0000 000000 0
W. Tozer Angel (individual) Minority 000 0000 000000 0
To view Bantam Pharmaceutical’s complete investors history, request access »

Bantam Pharmaceutical FAQs

  • When was Bantam Pharmaceutical founded?

    Bantam Pharmaceutical was founded in 2015.

  • Who is the founder of Bantam Pharmaceutical?

    Victor Keen is the founder of Bantam Pharmaceutical.

  • Who is the CEO of Bantam Pharmaceutical?

    Michael Stocum is the CEO of Bantam Pharmaceutical.

  • Where is Bantam Pharmaceutical headquartered?

    Bantam Pharmaceutical is headquartered in Durham, NC.

  • What is the size of Bantam Pharmaceutical?

    Bantam Pharmaceutical has 8 total employees.

  • What industry is Bantam Pharmaceutical in?

    Bantam Pharmaceutical’s primary industry is Drug Discovery.

  • Is Bantam Pharmaceutical a private or public company?

    Bantam Pharmaceutical is a Private company.

  • What is Bantam Pharmaceutical’s current revenue?

    The current revenue for Bantam Pharmaceutical is 000000.

  • How much funding has Bantam Pharmaceutical raised over time?

    Bantam Pharmaceutical has raised $32M.

  • Who are Bantam Pharmaceutical’s investors?

    Lionel Goldfrank, Victor Keen, and W. Tozer have invested in Bantam Pharmaceutical.

  • Who are Bantam Pharmaceutical’s competitors?

    NexImmune, Pfizer Pakistan, Gesynta Pharma, Cardurion Pharma, and Kite Pharma are some of the 8 competitors of Bantam Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »